-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-101 in Vitiligo
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-101 in Vitiligo Drug Details: PT-101 is under development for the treatment of ulcerative colitis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Neurodegenerative Diseases
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Neurodegenerative Diseases Drug Details: PT-00114 (TCAP-1) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-101 in Ulcerative Colitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-101 in Ulcerative Colitis Drug Details: PT-101 is under development for the treatment of ulcerative...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Substance (Drug) Abuse
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Substance (Drug) Abuse Drug Details: PT-00114 (TCAP-1) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Treatment Resistant Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Treatment Resistant Depression Drug Details: PT-00114 (TCAP-1) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Generalized Anxiety Disorder (GAD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Generalized Anxiety Disorder (GAD) Drug Details: PT-00114 (TCAP-1) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Post-Traumatic Stress Disorder (PTSD)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Post-Traumatic Stress Disorder (PTSD) Drug Details: PT-00114 (TCAP-1) is under development for the...
-
Product Insights
PT Indomining Mine
The PT Indomining Mine is a coal mine in Indonesia. It is currently in operation. Empower your strategies with our PT Indomining Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
PT KEL Mine
The PT KEL Mine is a coal mine in Indonesia. It is currently in operation. Empower your strategies with our PT KEL Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
PT Barasentosa Lestari Mine
The PT Barasentosa Lestari Mine is a coal mine in Indonesia. It is currently in operation. Empower your strategies with our PT Barasentosa Lestari Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...